Thu, August 18, 2022
Wed, August 17, 2022
Tue, August 16, 2022
Mon, August 15, 2022
Fri, August 12, 2022
Thu, August 11, 2022

Swayampakula Ramakanth Maintained (CASI) at Strong Buy with Increased Target to $12 on, Aug 15th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-12-on-aug-15th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Swayampakula Ramakanth of HC Wainwright & Co., Maintained "CASI Pharmaceuticals, Inc." (CASI) at Strong Buy with Increased Target from $3 to $12 on, Aug 15th, 2022.

Swayampakula has made no other calls on CASI in the last 4 months.



There are 2 other peers that have a rating on CASI. Out of the 2 peers that are also analyzing CASI, 0 agree with Swayampakula's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Swayampakula


  • Justin Zelin of "BTIG" Maintained at Strong Buy with Increased Target to $21 on, Friday, June 3rd, 2022
  • Sean Lee of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $30 on, Monday, May 16th, 2022

Publication Contributing Sources